Fatigue in Inflammatory Rheumatic Diseases: Current Knowledge and Areas for Future Research

Overview

Journal Nat Rev Rheumatol

Specialty Rheumatology

Date 2021 Oct 2

PMID 34599320

Citations 42

Authors

Kristen Davies

Emma Dures

Wan-Fai Ng

Affiliations

Soon will be listed here.

Abstract

Fatigue is a complex phenomenon and an important health concern for many people with chronic inflammatory rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, primary Sjögren syndrome and systemic lupus erythematosus. Although some clinical trials have shown the benefits of cognitive behavioural therapy in fatigue management, the effect of this approach is relatively modest, and no curative treatment has been identified. The pathogenesis of fatigue remains unclear. Despite many challenges and limitations, a growing body of research points to roles for the immune system, the central and autonomic nervous systems and the neuroendocrine system in the induction and maintenance of fatigue in chronic diseases. New insights indicate that sleep, genetic susceptibility, metabolic disturbances and other biological and physiological mechanisms contribute to fatigue. Furthermore, understanding of the relationships between psychosocial factors and fatigue is increasing. However, the interrelationships between these diverse mechanisms and fatigue remain poorly defined. In this Review, we outline various biological, physiological and psychosocial determinants of fatigue in inflammatory rheumatic diseases, and propose mechanistic and conceptual models of fatigue to summarize current understanding, stimulate debate and develop further research ideas.

Citing Articles

Investigation of the Effectiveness of a Biopsychosocial-Based Exercise Approach in Rheumatic Diseases: A Mixed Methods Research With Patients' Perspectives.

Unal E, Karaca N, Saldirdak G, Albayrak H, Ozcadirci A, Nacar N J Eval Clin Pract. 2025; 31(1):e70033.

PMID: 40012067 PMC: 11865290. DOI: 10.1111/jep.70033.

Factors associated with reduction in quality of life after SARS-CoV-2 infection.

Neumann C, Hartung T, Boje K, Bahmer T, Keil J, Lieb W Sci Rep. 2025; 15(1):6833.

PMID: 40000883 PMC: 11861590. DOI: 10.1038/s41598-025-91388-z.

Post-COVID general health symptoms in patients with immune-mediated inflammatory diseases.

van de Pol N, van der Woude C, Vis M, van Doorn M, Schrauwen S, Cetinozman-Teunissen F Eur J Gastroenterol Hepatol. 2025; 37(3):308-312.

PMID: 39919006 PMC: 11781538. DOI: 10.1097/MEG.0000000000002923.

What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives.

Mease P, Husni M, Siegel E, Furst D, Mcilraith M, Strand V ACR Open Rheumatol. 2025; 7(1):e11781.

PMID: 39800893 PMC: 11725532. DOI: 10.1002/acr2.11781.

Fatigue patterns surrounding biologic disease-modifying antirheumatic drug injection in patients with an inflammatory rheumatic disease: an ecological momentary assessment study.

van Lint J, Vriezekolk J, Jessurun N, den Broeder A, van den Bemt B, Huiskes V Rheumatol Int. 2025; 45(1):24.

PMID: 39797990 PMC: 11724786. DOI: 10.1007/s00296-024-05779-y.

References

Dures E, Fraser I, Almeida C, Peterson A, Caesley J, Pollock J . Patients' Perspectives on the Psychological Impact of Inflammatory Arthritis and Meeting the Associated Support Needs: Open-Ended Responses in a Multi-Centre Survey. Musculoskeletal Care. 2016; 15(3):175-185. DOI: 10.1002/msc.1159. View

Overman C, Kool M, da Silva J, Geenen R . The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol. 2015; 35(2):409-15. PMC: 4752960. DOI: 10.1007/s10067-015-3035-6. View

Dures E, Almeida C, Caesley J, Peterson A, Ambler N, Morris M . Patient preferences for psychological support in inflammatory arthritis: a multicentre survey. Ann Rheum Dis. 2014; 75(1):142-7. DOI: 10.1136/annrheumdis-2014-205636. View

Druce K, Basu N . Predictors of fatigue in rheumatoid arthritis. Rheumatology (Oxford). 2019; 58(Suppl 5):v29-v34. PMC: 6827266. DOI: 10.1093/rheumatology/kez346. View

Meijer J, Meiners P, Huddleston Slater J, Spijkervet F, Kallenberg C, Vissink A . Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford). 2009; 48(9):1077-82. DOI: 10.1093/rheumatology/kep141. View

Westhoff G, Dorner T, Zink A . Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study. Rheumatology (Oxford). 2011; 51(2):262-9. DOI: 10.1093/rheumatology/ker208. View

Basu N, McClean A, Harper L, Amft E, Dhaun N, Luqmani R . Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford). 2014; 53(5):953-6. DOI: 10.1093/rheumatology/ket483. View

Borrell-Carrio F, Suchman A, Epstein R . The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann Fam Med. 2004; 2(6):576-82. PMC: 1466742. DOI: 10.1370/afm.245. View

Ng W, Bowman S . Primary Sjogren's syndrome: too dry and too tired. Rheumatology (Oxford). 2010; 49(5):844-53. DOI: 10.1093/rheumatology/keq009. View

10.

Pope J . Management of Fatigue in Rheumatoid Arthritis. RMD Open. 2020; 6(1). PMC: 7299512. DOI: 10.1136/rmdopen-2019-001084. View

11.

Korte S, Straub R . Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms. Rheumatology (Oxford). 2019; 58(Suppl 5):v35-v50. PMC: 6827268. DOI: 10.1093/rheumatology/kez413. View

12.

Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D . Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum. 2005; 53(5):697-702. DOI: 10.1002/art.21450. View

13.

Primdahl J, Hegelund A, Lorenzen A, Loeppenthin K, Dures E, Esbensen B . The Experience of people with rheumatoid arthritis living with fatigue: a qualitative metasynthesis. BMJ Open. 2019; 9(3):e024338. PMC: 6475175. DOI: 10.1136/bmjopen-2018-024338. View

14.

Jones D, Gray J, Newton J . Perceived fatigue is comparable between different disease groups. QJM. 2009; 102(9):617-24. DOI: 10.1093/qjmed/hcp091. View

15.

Norheim K, Jonsson G, Omdal R . Biological mechanisms of chronic fatigue. Rheumatology (Oxford). 2011; 50(6):1009-18. DOI: 10.1093/rheumatology/keq454. View

16.

Bower J . Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014; 11(10):597-609. PMC: 4664449. DOI: 10.1038/nrclinonc.2014.127. View

17.

Jhamb M, Weisbord S, Steel J, Unruh M . Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis. 2008; 52(2):353-65. PMC: 2582327. DOI: 10.1053/j.ajkd.2008.05.005. View

18.

James K, Al-Ali S, Tarn J, Cockell S, Gillespie C, Hindmarsh V . A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome. PLoS One. 2015; 10(12):e0143970. PMC: 4687914. DOI: 10.1371/journal.pone.0143970. View

19.

Da Costa D, Dritsa M, Bernatsky S, Pineau C, Menard H, Dasgupta K . Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors. J Rheumatol. 2006; 33(7):1282-8. View

20.

Bruce I, Mak V, Hallett D, Gladman D, Urowitz M . Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999; 58(6):379-81. PMC: 1752900. DOI: 10.1136/ard.58.6.379. View